Trend Rising collection of human biological data creating misuse risk
Summary
The acquisition and use of human biological data, such as genetic information, biometrics and personal health and fitness data, is growing quickly. The report sees these data as bringing major benefits for healthcare, wellbeing and personalised services, but also as carrying a risk of deliberate misuse. Misuse could infringe individual privacy rights and could be exploited by threat actors for strategic advantage. As genome sequencing costs have plunged, private firms have begun offering consumers access to their own biological data, and the split between public and private ownership creates challenges for access, diversity and oversight. The report lists biometric surveillance, targeting people by genomic profile and insurer access to data as ethical concerns, and it describes biological data as increasingly treated as a strategic resource by businesses and states.
Classification
Evidence 1
- HM Government - Cabinet Office and Government Office for Science (Foresight) Chronic Risks Analysis HM Government - Cabinet Office and Government Office for Science (Foresight) no link — bibliographic entry p. 109 2025 accessed 2026-09-29
Observed signals 5
- Signal2018 Code on Genetic Testing and Insurance limits genomic data in insurance
- SignalAbout 21% of US adults used smartwatches or fitness trackers by 2019
- SignalConsumer DNA firm sold over 12 million kits and filed for bankruptcy in 2025
- SignalGenome sequencing cost fell from 300 million dollars to 525 dollars
- SignalUK Biobank holds data on half a million participants
Part of issues 4
- IssueBiological data arms races and state data hacks1 trends · 0 signals
- IssueGenetic discrimination from routine use of biological data1 trends · 0 signals
- IssueGenome sequencing at birth integrated with NHS records1 trends · 0 signals
- IssueVulnerable persons and biological data at the end of risk cascades2 trends · 0 signals
Relation types: constitutes · supports
Public id: fm-b0c95189a8cb
